NASDAQ · IMDX
Insight Molecular Diagnostics Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for IMDX: Nov 9, 2026
Insight Molecular Diagnostics Inc. Common Stock is estimated to report earnings on 11/09/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. The reported EPS for the same quarter last year was $-0.34.
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
The Motley Fool · MarketBeat · BNK Invest · Fintel- The Motley Fool · Aug 17, 5:28 PM EDTInsight Molecular Diagnostics (IMDX) Q2 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- MarketBeat · Aug 17, 2:02 PM EDTOncocyte Eyes Faster, Less Invasive Heart Transplant Rejection TestingInsight Molecular Diagnostics discussed the potential use of donor-derived cell-free DNA testing in heart transplant surveillance during a virtual session featuring transplant cardiologist Dr. Max Liebo of Loyola University. Chief Executive Officer Josh Riggs said the company’s
- MarketBeat · Aug 10, 8:04 PM EDTOncocyte Q2 Earnings Call HighlightsOncocyte (NASDAQ:IMDX) executives said they continue to target FDA marketing authorization for the GraftAssureDx kidney-transplant rejection test later this year, while preparing for a commercial launch and managing spending ahead of expected revenue growth. During the company’s
- The Motley Fool · May 13, 6:05 PM EDTIMDX Q1 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- BNK Invest · May 4, 12:34 PM EDTMonday Sector Leaders: Biotechnology, Oil & Gas Refining & Marketing StocksIn trading on Monday, biotechnology shares were relative leaders, up on the day by about 2.1%. Leading the group were shares of Insight Molecular Diagnostics, up about 22.8% and shares of Replimune Group up about 20.8% on the day. Also showing relative strength are oil & g
- BNK Invest · Apr 14, 12:06 PM EDTTuesday Sector Leaders: Biotechnology, Medical Instruments & SuppliesIn trading on Tuesday, biotechnology shares were relative leaders, up on the day by about 3.4%. Leading the group were shares of Travere Therapeutics, up about 34.1% and shares of Insight Molecular Diagnostics up about 33% on the day. Also showing relative strength are medical
- Fintel · Feb 24, 9:27 PM ESTInsight Molecular Diagnostics (IMDX) Price Target Increased by 19.05% to 8.50The average one-year price target for Insight Molecular Diagnostics (NasdaqCM:IMDX) has been revised to $8.50 / share. This is an increase of 19.05% from the prior estimate of $7.14 dated February 1, 2026. The price target is an average of many targets provide
- Fintel · Nov 16, 6:24 PM ESTInsight Molecular Diagnostics (IMDX) Price Target Increased by 29.23% to 7.14The average one-year price target for Insight Molecular Diagnostics (NasdaqCM:IMDX) has been revised to $7.14 / share. This is an increase of 29.23% from the prior estimate of $5.53 dated November 7, 2025. The price target is an average of many targets provide
- Fintel · Nov 11, 7:03 AM ESTNeedham Maintains Insight Molecular Diagnostics (IMDX) Buy RecommendationFintel reports that on November 11, 2025, Needham maintained coverage of Insight Molecular Diagnostics (NasdaqCM:IMDX) with a Buy recommendation. Analyst Price Forecast Suggests 18.75% Downside
- Zacks · Jul 15, 9:20 AM EDT3 Medical Info Systems Stocks to Buy Amid AI Boom and Tariff RiskAI momentum and rising demand for digital care put Zacks Medical Info Systems industry stocks like VEEV, TXG and IMDX in focus despite new tariff headwinds.
- Quiver Quantitative · Jun 23, 4:12 PM EDTiMDx Announces Positive Study Results Showing Equivalence of GraftAssureIQ with NGS dd-cfDNA Test Kits in Kidney Transplant MonitoringStudy shows iMDx test equivalent to NGS kits for dd-cfDNA measurement in kidney transplant patients, supporting future commercialization efforts.
- Quiver Quantitative · May 23, 4:20 AM EDTNew Analyst Forecast: $OCX Given $8.0 Price TargetWe just received data on a new analyst forecast for $OCX. Thomas Flaten from UBS set a price target of 8.0 for OCX.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Insight Molecular Diagnostics Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.